DQP-997-74 is a selective inhibitor of the N-methyl-D-aspartate receptor (NMDAR), specifically targeting GluN2C/D subunits (IC50: 0.069 μM and 0.035 μM), with blood-brain barrier permeability; it reduces seizure frequency in a tuberous sclerosis complex (TSC)-induced epileptic mouse model and can be used for the study of NMDAR-related neurological disorders.